Mechanistic comparison of Carbimazole and Isoniazid Antibacterial agent used primarily as based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
5
Shared Targets
45%
Jaccard Similarity
36%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Carbimazole and Isoniazid share 5 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.455 means 45% of the combined target set is bound by both compounds. The IDF-weighted score of 0.355 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Carbimazole and Isoniazid have in common?
Carbimazole and Isoniazid share 5 molecular targets with a Jaccard similarity of 45%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Carbimazole and Isoniazid be combined?
Carbimazole and Isoniazid share 5 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Carbimazole or Isoniazid?
Both Carbimazole and Isoniazid have substantial PubMed research. View their individual profiles for full evidence scores.